After a strong 6 months that has seen the best growth spurt in its history, Lonza is raising its guidance for the rest of the year.

Germany’s hybrid CRO-biotech Evotec has had a better few months than expected as it announces stronger profits for 2016 ahead of its half-year results on Aug.…

A new paper published in the journal Computer argues that personal health information must be better secured with increased privacy settings--or risk PHI…

The personal genome company 23andMe has launched a new platform that will allow researchers to see and track certain genetic information from patients in their…

The pharma services industry continues to buck a negative trend as Patheon sets its terms for an eye-watering $625 million initial public offering.

Drilling deeper into its drug discovery platform, hybrid biotech-CRO Evotec has signed a deal with British charity Antibiotic Research UK to help older…

Two major academic medical centers have been given a 7-year, $26.5 million cash boost from the U.S. government to help weed out inefficiencies in clinical…

San Bruno, CA-based PRC Clinical is expanding both its gene therapy and Parkinson's disease offerings for an undisclosed Boston sponsor.